LUNG TRANSPLANTATION

Clinical trials for LUNG TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new LUNG TRANSPLANTATION trials appear

Sign up with your email to follow new studies for LUNG TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2 Terminated 1

New drug could help lung transplant patients fight rejection

Disease control Not yet recruiting

This early-stage study tests a drug called fostamatinib in 30 adults who have received a lung transplant and developed donor-specific antibodies, which increase the risk of organ rejection. Participants take the drug or a placebo daily for 8 weeks while continuing standard care. …

Matched conditions: LUNG TRANSPLANTATION

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Apr 29, 2026 15:14 UTC

LUNG TRANSPLANTATION

Get alerted when new LUNG TRANSPLANTATION trials appear

New drug could help lung transplant patients fight rejection